Li Xiting

Li Xiting — founder profiled in the Chinese Founder Ledger — is documented as follows: university of Science and Technology of China physics graduate who worked as a researcher in Wuhan and France before co-founding medical-device maker Mindray in Shenzhen in 1991 with Xu Hang and Cheng Minghe, growing it into China's largest medical equipment manufacturer, listing it on the NYSE in 2006, taking it private in a 2016 buyout, and relisting it on China's A-share market; he became a naturalized Singaporean citizen in 2018. The profile is grounded in the 2 sources indexed for this founder.

Li Xiting's role is documented as: co-founder and President of Mindray; also serves as chairman per Mindray's own corporate infobox Wikipedia describes his years active as '1991-present' and his title as 'Co-founder and president of Mindray,' while Mindray's own Wikipedia infobox separately lists Li Xiting as 'chairman' (research date: 2026-08-23); the apparent discrepancy between 'president' and 'chairman' framing across sources was not resolved with a primary Mindray filing in this pass.

Li was born in a rural village in Dangshan County, Anhui, in 1951, graduated from the University of Science and Technology of China with a bachelor's degree in low-temperature physics, and worked as a researcher assisting scholars in Wuhan, Hubei and in France (including as a visiting scholar at Paris-Sud University) from 1976 to 1987.

Li's first entrepreneurial venture was at Shenzhen Anke High-tech Company, a partially state-owned enterprise set up by the Chinese Academy of Sciences, which became China's first home-grown developer of medical devices and launched the country's first MRI scanner in 1989.

Li founded Mindray in Shenzhen in 1991 together with Xu Hang and Cheng Minghe, both former Anke colleagues; the company secured its first contract, a 360,000-yuan sale, at a medical equipment convention in the 1990s, and by 2008 had become China's largest medical device manufacturer.

Mindray listed on the New York Stock Exchange in September 2006, raising US$270 million; in 2016, Li and his two co-founders took the company private in a US$1.9 billion deal, and the company subsequently re-listed on China's A-share market.

Li moved to Singapore and became a naturalized citizen in 2018; during the COVID-19 pandemic, his net worth was estimated to have grown substantially, per Wikipedia (specific dollar figures were truncated in the fetched content and not independently confirmed in this pass).

Mindray successfully transitioned from a NYSE-listed company (delisted March 2016 per the buyout) to relisting on China's domestic A-share market (Shenzhen Stock Exchange, ticker 300760), and grew into a company reporting US$5.1 billion in 2024 revenue.

As of Mindray's Wikipedia company profile, the firm reported 2024 revenue of US$5.1 billion, operating income of US$1.54 billion, and net income of US$1.46 billion, with about 21,000 employees as of 2025 and operations spanning 41 subsidiaries and branch offices across 31 countries plus 32 branch offices within China.